Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ: CODX )

0.7300 +0.0048 (+0.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 170,869
Open 0.7300
Bid (Size) 0.7200 (3)
Ask (Size) 0.7300 (51)
Prev. Close 0.7252
Today's Range 0.7210 - 0.7650
52wk Range 0.7000 - 2.230
Shares Outstanding 31,929,752
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Performance

YTD
-48.59%
-48.59%
1 Month
-31.13%
-31.13%
3 Month
-39.67%
-39.67%
6 Month
-47.48%
-47.48%
1 Year
-36.52%
-36.52%

More News

Read More
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Peering Into Co-Diagnostics's Recent Short Interest
Via Benzinga
Co-Diagnostics: Q4 Earnings Insights
Via Benzinga
Earnings Preview: Co-Diagnostics
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
Via Benzinga
Exposures COVID-19
Preview: Co-Diagnostics's Earnings
Via Benzinga
Earnings Scheduled For March 14, 2024
Via Benzinga
Co-Diagnostics Earnings Perspective: Return On Invested Capital
Via Benzinga
Preview: Co-Diagnostics's Earnings
Via Benzinga
7 Doomed Growth Stocks Destined for Disaster
Via InvestorPlace
Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Co-Diagnostics, Inc. (NASDAQ:CODX) Long Term Shareholder Notice: Investigation over Possible Wrongdoing
Via SBWire
Co-Diagnostics's Earnings Outlook
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CODX FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - CODX
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
CO-DX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Co-Diagnostics, Inc. (CODX) and Encourages Long-Term CODX Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.